Featured Products

My Quote Request

No products added yet

6505-01-068-3545

20 Products

NDC00140-0071-14

CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505010683545

NSN

6505-01-068-3545

View More Info

NDC00140-0071-14

CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505010683545

NSN

6505-01-068-3545

MFG

HOFFMANN-LA ROCHE INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS AMITRIPTYLINE HYDROCHLORIDE ACTIVE INGREDIENT AND 10.000 MILLIGRAMS CHLORDIAZEPOXIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

NDC00338-0481-98

FAT EMULSION INJECTION

NSN, MFG P/N

6505010674822

NSN

6505-01-067-4822

View More Info

NDC00338-0481-98

FAT EMULSION INJECTION

NSN, MFG P/N

6505010674822

NSN

6505-01-067-4822

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.250 PERCENTAGE, V/V GLYCERIN ACTIVE INGREDIENT AND 10.000 PERCENTAGE, V/V SOYBEAN OIL ACTIVE INGREDIENT AND 1.200 PCT W/V EGG YOLK PHOSPHOLIPIDS ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: W/INTRAVENOUS INJECTION SET

TRAVAMULSION 10 PCT

FAT EMULSION INJECTION

NSN, MFG P/N

6505010674822

NSN

6505-01-067-4822

View More Info

TRAVAMULSION 10 PCT

FAT EMULSION INJECTION

NSN, MFG P/N

6505010674822

NSN

6505-01-067-4822

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.250 PERCENTAGE, V/V GLYCERIN ACTIVE INGREDIENT AND 10.000 PERCENTAGE, V/V SOYBEAN OIL ACTIVE INGREDIENT AND 1.200 PCT W/V EGG YOLK PHOSPHOLIPIDS ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: W/INTRAVENOUS INJECTION SET

15902PX

MAGNESIUM SULFATE INJECTION,USP

NSN, MFG P/N

6505010674849

NSN

6505-01-067-4849

View More Info

15902PX

MAGNESIUM SULFATE INJECTION,USP

NSN, MFG P/N

6505010674849

NSN

6505-01-067-4849

MFG

INVENEX LABORATORIES LIFE TECHNOLOGIES INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 PERCENTAGE, W/V MAGNESIUM SULFATE ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 2 ML. IN A 6 ML. PARTIAL FILL SINGLE DOSE VIAL WITH FLIP-OFF TOP; MUST BE DILUTED BEFORE INTRAVENOUS USE

NDC00467-0159-25

MAGNESIUM SULFATE INJECTION,USP

NSN, MFG P/N

6505010674849

NSN

6505-01-067-4849

View More Info

NDC00467-0159-25

MAGNESIUM SULFATE INJECTION,USP

NSN, MFG P/N

6505010674849

NSN

6505-01-067-4849

MFG

INVENEX LABORATORIES LIFE TECHNOLOGIES INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 PERCENTAGE, W/V MAGNESIUM SULFATE ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 2 ML. IN A 6 ML. PARTIAL FILL SINGLE DOSE VIAL WITH FLIP-OFF TOP; MUST BE DILUTED BEFORE INTRAVENOUS USE

NDC00093-0262-15

FLUOCINONIDE CREAM,USP

NSN, MFG P/N

6505010674850

NSN

6505-01-067-4850

View More Info

NDC00093-0262-15

FLUOCINONIDE CREAM,USP

NSN, MFG P/N

6505010674850

NSN

6505-01-067-4850

MFG

LEMMON CO

Description

ACTIVE INGREDIENT AND STRENGTH: 0.050 FLUOCINONIDE PERCENTAGE, W/W
ADMINISTRATION: TOPICAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLUOCINONIDE CREAM USP 15GM TUBE
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SPECIAL FEATURES: WATER WASHABLE,AQUEOUS MINERAL OIL BASE

NDC49158-0212-20

FLUOCINONIDE CREAM,USP

NSN, MFG P/N

6505010674850

NSN

6505-01-067-4850

View More Info

NDC49158-0212-20

FLUOCINONIDE CREAM,USP

NSN, MFG P/N

6505010674850

NSN

6505-01-067-4850

MFG

THAMES PHARMACAL CO INC

Description

ACTIVE INGREDIENT AND STRENGTH: 0.050 FLUOCINONIDE PERCENTAGE, W/W
ADMINISTRATION: TOPICAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLUOCINONIDE CREAM USP 15GM TUBE
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SPECIAL FEATURES: WATER WASHABLE,AQUEOUS MINERAL OIL BASE

HYDERGINE TABLETS

ERGOLOID MESYLATES TABLETS,USP

NSN, MFG P/N

6505010675324

NSN

6505-01-067-5324

View More Info

HYDERGINE TABLETS

ERGOLOID MESYLATES TABLETS,USP

NSN, MFG P/N

6505010675324

NSN

6505-01-067-5324

MFG

NOVARTIS PHARMACEUTICALS CORPORATION

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.333 MILLIGRAMS DIHYDROERGOCORNINE MESYLATE ACTIVE INGREDIENT AND 0.333 MILLIGRAMS DIHYDROERGOCRISTINE MESYLATE ACTIVE INGREDIENT AND 0.333 MILLIGRAMS DIHYDROERGOCRYPTINE MESYLATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ERGOLOID MESYLATES TABLETS USP 1 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: TOTAL 1 MG

NDC00078-0070-05

ERGOLOID MESYLATES TABLETS,USP

NSN, MFG P/N

6505010675324

NSN

6505-01-067-5324

View More Info

NDC00078-0070-05

ERGOLOID MESYLATES TABLETS,USP

NSN, MFG P/N

6505010675324

NSN

6505-01-067-5324

MFG

NOVARTIS PHARMACEUTICALS CORPORATION

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.333 MILLIGRAMS DIHYDROERGOCORNINE MESYLATE ACTIVE INGREDIENT AND 0.333 MILLIGRAMS DIHYDROERGOCRISTINE MESYLATE ACTIVE INGREDIENT AND 0.333 MILLIGRAMS DIHYDROERGOCRYPTINE MESYLATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ERGOLOID MESYLATES TABLETS USP 1 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: TOTAL 1 MG

NDC00536-3856-01

ERGOLOID MESYLATES TABLETS,USP

NSN, MFG P/N

6505010675324

NSN

6505-01-067-5324

View More Info

NDC00536-3856-01

ERGOLOID MESYLATES TABLETS,USP

NSN, MFG P/N

6505010675324

NSN

6505-01-067-5324

MFG

RUGBY GROUP INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.333 MILLIGRAMS DIHYDROERGOCORNINE MESYLATE ACTIVE INGREDIENT AND 0.333 MILLIGRAMS DIHYDROERGOCRISTINE MESYLATE ACTIVE INGREDIENT AND 0.333 MILLIGRAMS DIHYDROERGOCRYPTINE MESYLATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ERGOLOID MESYLATES TABLETS USP 1 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: TOTAL 1 MG

ALM11778

INFLUENZA VIRUS VACCINE,USP

NSN, MFG P/N

6505010679533

NSN

6505-01-067-9533

View More Info

ALM11778

INFLUENZA VIRUS VACCINE,USP

NSN, MFG P/N

6505010679533

NSN

6505-01-067-9533

MFG

DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA

Description

ADSORBENT: ANY ACCEPTABLE
ADSORBENT MATERIAL: ANY ACCEPTABLE
DESIGN CONTROL REFERENCE: ALM11778
IMMEDIATE CONTAINER QUANTITY: 1
IMMEDIATE CONTAINER TYPE: BOTTLE
MANUFACTURERS CODE: 89875
QUANTITY WITHIN EACH IMMEDIATE CONTAINER: 10 DOSES
SPECIAL FEATURES: SPLIT VIRUS ONLY; 0.5 ML PER DOSE; FOR NON-MILITARY PERSONS 6 MONTHS TO 25 YEARS OF AGE
THE MANUFACTURERS DATA:
VALENCE: POLYVALENT
VIRUS STRAIN: A/USSR STRAIN 20 UG MINIMUM HEMAGGLUTININ PER DOSE; A/TEXAS STRAIN 7 UG MINIMUM HEMAGGLUTININ PER DOSE; B/HONG KONG STRAIN 7 UG MINIMUM HEMAGGLUTININ PER DOSE

2A6433

AMINO ACIDS INJECTION WITH ELECTROLYTES

NSN, MFG P/N

6505010679753

NSN

6505-01-067-9753

View More Info

2A6433

AMINO ACIDS INJECTION WITH ELECTROLYTES

NSN, MFG P/N

6505010679753

NSN

6505-01-067-9753

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 8.500 PERCENTAGE,W/V AMINO ACIDS ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACIDS INJECTION WITH ELECTROLYTES 8.5% 500ML 12S BT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: NONPYROGENIC,HYPERTONIC
TOTAL PRIMARY CONTAINER QUANTITY: 12

AMINOSYN

AMINO ACIDS INJECTION WITH ELECTROLYTES

NSN, MFG P/N

6505010679753

NSN

6505-01-067-9753

View More Info

AMINOSYN

AMINO ACIDS INJECTION WITH ELECTROLYTES

NSN, MFG P/N

6505010679753

NSN

6505-01-067-9753

MFG

ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 8.500 PERCENTAGE,W/V AMINO ACIDS ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACIDS INJECTION WITH ELECTROLYTES 8.5% 500ML 12S BT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: NONPYROGENIC,HYPERTONIC
TOTAL PRIMARY CONTAINER QUANTITY: 12

NDC00074-5856-03

AMINO ACIDS INJECTION WITH ELECTROLYTES

NSN, MFG P/N

6505010679753

NSN

6505-01-067-9753

View More Info

NDC00074-5856-03

AMINO ACIDS INJECTION WITH ELECTROLYTES

NSN, MFG P/N

6505010679753

NSN

6505-01-067-9753

MFG

ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 8.500 PERCENTAGE,W/V AMINO ACIDS ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACIDS INJECTION WITH ELECTROLYTES 8.5% 500ML 12S BT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: NONPYROGENIC,HYPERTONIC
TOTAL PRIMARY CONTAINER QUANTITY: 12

NDC00338-0459-03

AMINO ACIDS INJECTION WITH ELECTROLYTES

NSN, MFG P/N

6505010679753

NSN

6505-01-067-9753

View More Info

NDC00338-0459-03

AMINO ACIDS INJECTION WITH ELECTROLYTES

NSN, MFG P/N

6505010679753

NSN

6505-01-067-9753

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 8.500 PERCENTAGE,W/V AMINO ACIDS ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACIDS INJECTION WITH ELECTROLYTES 8.5% 500ML 12S BT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: NONPYROGENIC,HYPERTONIC
TOTAL PRIMARY CONTAINER QUANTITY: 12

TRAVASOL

AMINO ACIDS INJECTION WITH ELECTROLYTES

NSN, MFG P/N

6505010679753

NSN

6505-01-067-9753

View More Info

TRAVASOL

AMINO ACIDS INJECTION WITH ELECTROLYTES

NSN, MFG P/N

6505010679753

NSN

6505-01-067-9753

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 8.500 PERCENTAGE,W/V AMINO ACIDS ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACIDS INJECTION WITH ELECTROLYTES 8.5% 500ML 12S BT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: NONPYROGENIC,HYPERTONIC
TOTAL PRIMARY CONTAINER QUANTITY: 12

5647-25

DEXTROSE INJECTION,USP

NSN, MFG P/N

6505010683308

NSN

6505-01-068-3308

View More Info

5647-25

DEXTROSE INJECTION,USP

NSN, MFG P/N

6505010683308

NSN

6505-01-068-3308

MFG

ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 70.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROSE INJECTION USP 70% DEXTROSE 500ML 6S GLASS BT
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ABBOTT LABS
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, GLASS
SPECIAL FEATURES: PARTIAL FILL 500 ML IN 1000 ML I.V. BOTTLE; FOR DILUTION
TOTAL PRIMARY CONTAINER QUANTITY: 6

NDC00074-5647-25

DEXTROSE INJECTION,USP

NSN, MFG P/N

6505010683308

NSN

6505-01-068-3308

View More Info

NDC00074-5647-25

DEXTROSE INJECTION,USP

NSN, MFG P/N

6505010683308

NSN

6505-01-068-3308

MFG

ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 70.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROSE INJECTION USP 70% DEXTROSE 500ML 6S GLASS BT
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ABBOTT LABS
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, GLASS
SPECIAL FEATURES: PARTIAL FILL 500 ML IN 1000 ML I.V. BOTTLE; FOR DILUTION
TOTAL PRIMARY CONTAINER QUANTITY: 6

NDC00472-1467-16

DETERGENT,SURGICAL

NSN, MFG P/N

6505010683543

NSN

6505-01-068-3543

View More Info

NDC00472-1467-16

DETERGENT,SURGICAL

NSN, MFG P/N

6505010683543

NSN

6505-01-068-3543

MFG

NATIONAL PHARMACEUTICAL MFG CO A DIV OF BARRE-NATIONAL INC SUB OF REVCO D S INC

Description

INGREDIENT CLASSIFICATION: MEDICATED
QUANTITY WITHIN EACH UNIT PACKAGE: 16.000 FLUID OUNCES
STRENGTH: POVIDONE-IODINE EQUIVALENT TO 0.5 PERCENT AVAILABLE IODINE

LIMBITROL 10-25

CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505010683545

NSN

6505-01-068-3545

View More Info

LIMBITROL 10-25

CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505010683545

NSN

6505-01-068-3545

MFG

HOFFMANN-LA ROCHE INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS AMITRIPTYLINE HYDROCHLORIDE ACTIVE INGREDIENT AND 10.000 MILLIGRAMS CHLORDIAZEPOXIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE